trending Market Intelligence /marketintelligence/en/news-insights/trending/dADL0kM0tXNt_uuFhgydaQ2 content esgSubNav
In This List

Immune Pharmaceuticals appoints COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Immune Pharmaceuticals appoints COO

Immune Pharmaceuticals Inc. appointed Tony Fiorino to the joint position of chief medical officer and COO of the company.

Fiorino previously served as president and CEO of Triumvira Immunologics, an immuno-oncology company developing an engineered T cell platform.